If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

6th July, 2021

Validation of the CAAT in NOVELTY ePoster Presented at ATS 2021

Home > News & events > Validation of the CAAT in NOVELTY ePoster Presented at ATS 2021

We are pleased to announce that the validation of the Chronic Airways Assessment Test (CAAT) was presented as an ePoster at the American Thoracic Society (ATS) International Conference, 14–19 May 2021. This analysis found that the CAAT questionnaire was consistent with other health status questionnaires, and can be useful for patients with asthma and/or COPD in the clinical practice setting. Read more

19 PARTICIPATING COUNTRIES^a

~12,000 ENROLLED PATIENTS^a

84% OF PATIENTS HAVE SPIROMETRY DATA^b

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study